Candesartan cilexetil induced pustular psoriasis

Area of Science:

• Dermatology
• Pharmacology
• Hypertension Management

Background:

• Pustular eruptions are rare adverse effects of antihypertensive medications, with previous reports involving beta-blockers, calcium channel blockers, and ACE inhibitors.
• Angiotensin II type 1 (AT1) receptor antagonists are a widely used class of antihypertensive drugs.
• Generalized pustular psoriasis is a severe dermatological condition.

Observation:

• A patient with a history of flexural psoriasis developed generalized pustular psoriasis.
• The patient was treated with candesartan cilexetil, an AT1 receptor antagonist, for hypertension.
• This represents a novel association between AT1 receptor antagonists and pustular psoriasis.

Findings:

• The development of generalized pustular psoriasis in this patient suggests a potential link with candesartan cilexetil.
• While AT1 receptor antagonists are not typically associated with increased bradykinin levels, the findings suggest a possible indirect effect or alternative mechanism.
• This case indicates that AT1 receptor antagonists might possess some bradykinin-upregulating potency, similar to ACE inhibitors, in susceptible individuals.

Implications:

• This case report expands the known spectrum of drug-induced pustular eruptions.
• It raises awareness among clinicians regarding the potential for AT1 receptor antagonists to induce pustular psoriasis in patients with pre-existing psoriasis.
• Further research is warranted to elucidate the precise mechanisms by which AT1 receptor antagonists may trigger pustular psoriasis.